As the PP2A therapeutics have been able to sensitize cancer cells to well-known chemotherapeutics or radiation therapy, it brings these compounds into further significance, especially in the case of drug-resistant cancer, which requires more avenues of addressing ways to sensitize these cancers with PP2A modulators being one such possibility. This evidence concerns the gene PTPA and cancer.